In July 2012, the FDA approved the daily pill Truvada for use as PrEP, the first pre-exposure prophylaxis to prevent HIV. But only recently has word really been getting out—as in outside the white gay community. Here’s a roundup of new promotions:

  • Project Inform offers a free booklet “Transcending Barriers for Safer Pleasure” on PrEP for transgender women, plus other PrEP publications in Spanish and inclusive of transgender men who have sex with men.
  • The East Bay AIDS Center in Oakland, California, launched CRUSH to help young gay men of color access PrEP and sexual health services, to great success.
  • In Atlanta, which has the nation’s fifth-highest rate of new HIV cases, a no-cost clinic focused on PrEP opened, thanks to funding from Truvada maker Gilead Sciences. The clinic focuses on women in high-risk groups, young gay men, and negative folks with an HIV-positive partner.
  • Confused about PrEP? Then visit #AskTheHIVDoc (pictured above) for their fast and fun YouTube series of Q&As. Drop-ins are welcome!